Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
L
Les Entreprises Du Medicament
Business AssociationsFrance
Last verified 9 days ago
Les Entreprises Du Medicament, commonly referred to as LEDM, is a prominent business association based in France. Headquartered in Paris, the organisation primarily operates across the European pharmaceutical and healthcare sectors, supporting companies involved in medication development, manufacturing, and distribution. Founded in the early 2000s, LEDM has established itself as a key industry advocate, fostering collaboration and innovation within the pharmaceutical community.
The association’s core services include industry advocacy, regulatory support, and facilitating networking opportunities for members. Its members benefit from specialised insights into market trends, compliance requirements, and research advancements. Recognised for its influential role in shaping pharmaceutical policies, Les Entreprises Du Medicament holds a notable position within the European healthcare industry, contributing to the advancement of safe and effective medication practices.
34
DitchCarbon score
+14 vs industry average
Les Entreprises Du Medicament’s score of 34 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Les Entreprises Du Medicament?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Business Associations has below-average carbon intensity
Industry performance
0.199
20182025
The Business Associations industry has reduced its overall emissions by 37% since 2018
Reported emissions
No reported emissions data is available for Les Entreprises Du Medicament yet.
Les Entreprises Du Medicament's reported carbon emissions
Les Entreprises Du Medicament, a French business association, currently has no publicly available carbon emissions data.
However, the organisation has established several climate commitments. Notably, it aims for a 50% reduction in CO2 emissions across all scopes (Scopes 1, 2, and 3) by 2030, using 2015 as a baseline year. This target also includes a specific goal for Scopes 1 and 2, aiming for a 50% reduction by 2030 from a 2021 baseline. The organisation has also set a long-term goal to reduce Scope 1 and Scope 2 emissions by 80% by 2050, with a 1990 baseline year.
Assessing Les Entreprises Du Medicament as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Les Entreprises Du Medicament and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Les Entreprises Du Medicament’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Les Entreprises Du Medicament
FRBusiness Associations9 days ago
34
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more